Agios Pharma (AGIO) Misses Q4 EPS by 8c

Agios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($1.41), $0.08 worse than the analyst estimate of ($1.33). Revenue for the quarter came in at $44 million versus the consensus estimate of $40.17 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group
• Pfizer reafffirms 2026 guidance after CFO transition announcement